Niki BioSolutions, Inc. (NIKI) Change in Accured Expenses (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Change in Accured Expenses came in at $76300.0 in Q4 2025, up 193.42% YoY from $26003.3 in Q4 2024, and down 79.11% on a QoQ basis from $365238.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Change in Accured Expenses (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of Change in Accured Expenses data on file, last reported at $76300.0 in Q4 2025.
- Quarterly Change in Accured Expenses rose 193.42% year-over-year to $76300.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $454479.0 (changed N/A YoY) and the FY2025 annual result came in at -$28368.0, up 93.29% from the prior year.
- Change in Accured Expenses retreated to $76300.0 in Q4 2025, from $365238.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $365238.0 in Q3 2025 to a low of -$81670.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 76,300.00 |
| Nov 30, 2025 | 76,300.00 |
| Aug 31, 2025 | 365,238.00 |
| Aug 31, 2025 | 365,238.00 |
| Nov 30, 2024 | -81,670.00 |
| Nov 30, 2024 | -81,670.00 |
| Aug 31, 2024 | 94,611.00 |
| Aug 31, 2024 | 94,611.00 |
| Dec 31, 2017 | 183,083.00 |
| Dec 31, 2017 | 183,083.00 |